Literature DB >> 11567806

The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region.

B O'Sullivan1, P Warde, B Grice, C Goh, D Payne, F F Liu, J Waldron, A Bayley, J Irish, P Gullane, B Cummings.   

Abstract

PURPOSE: Ipsilateral techniques designed to restrict treatment to the primary tumor and neck on the same side have been used in selected cases of cases of carcinoma of the tonsillar region at our institution for many years. The primary purpose of this study is to evaluate the risk of failure in the opposite neck in cases selected for unilateral radiotherapy over a 21-year period. METHODS AND MATERIALS: Ipsilateral radiotherapy techniques were used in 228 of 642 patients with carcinoma of the tonsillar region from 1970 to 1991. Local control, regional lymph-node control (including contralateral failure), and survival were calculated for different degrees of tumor extent treated with these techniques.
RESULTS: Mean follow-up was 7 years. Cases tended to be T1 and T2, with N0 disease. The 3-year actuarial local control rate was 77% and cause-specific survival was 76%. Opposite neck failure was seen in 8 patients (crude rate of 3.5%). In the earlier period of the study, primary coverage was problematic in a proportion of cases and resulted in higher rates of local failure.
CONCLUSION: Appropriately selected cases of carcinoma of the tonsil show minimal risk of failure in the opposite neck with ipsilateral techniques. Patients should undergo computed tomography planning to ensure adequate target coverage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11567806     DOI: 10.1016/s0360-3016(01)01613-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  28 in total

1.  Heterogeneity in head and neck IMRT target design and clinical practice.

Authors:  Theodore S Hong; Wolfgang A Tomé; Paul M Harari
Journal:  Radiother Oncol       Date:  2012-03-09       Impact factor: 6.280

2.  Unilateral neck therapy in the human papillomavirus ERA: accepted regional spread patterns.

Authors:  Thomas J Galloway; Miriam N Lango; Barbara Burtness; Ranee Mehra; Karen Ruth; John A Ridge
Journal:  Head Neck       Date:  2012-02-02       Impact factor: 3.147

Review 3.  Intensity-modulated radiotherapy: is xerostomia still prevalent?

Authors:  Mark S Chambers; Adam S Garden; David Rosenthal; Anesa Ahamad; David L Schwartz; Angel I Blanco; K S Clifford Chao; William H Morrison; K Kian Ang; Randal S Weber
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

Review 4.  Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.

Authors:  Avraham Eisbruch; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2009-01       Impact factor: 5.934

5.  The potential of helical tomotherapy in the treatment of head and neck cancer.

Authors:  Dirk Van Gestel; Dirk Verellen; Lien Van De Voorde; Bie de Ost; Geert De Kerf; Olivier Vanderveken; Carl Van Laer; Danielle Van den Weyngaert; Jan B Vermorken; Vincent Gregoire
Journal:  Oncologist       Date:  2013-05-30

6.  SPECT/CT-guided lymph drainage mapping for the planning of unilateral elective nodal irradiation in head and neck squamous cell carcinoma.

Authors:  Pieter D de Veij Mestdagh; Marcel C J Jonker; Wouter V Vogel; Willem H Schreuder; Maarten L Donswijk; W Martin C Klop; Abrahim Al-Mamgani
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-28       Impact factor: 2.503

7.  Radiotherapy alone or combined with chemotherapy as definitive treatment for squamous cell carcinoma of the tonsil.

Authors:  William R Kennedy; Michael P Herman; Rohan L Deraniyagala; Robert J Amdur; John W Werning; Peter Dziegielewski; Jessica Kirwan; Christopher G Morris; William M Mendenhall
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-08       Impact factor: 2.503

8.  Retrospective analysis of the treatment results for patients with squamous cell carcinoma of tonsil.

Authors:  Ah Ram Chang; Hong-Gyun Wu; Charn Il Park; Kwang-Hyun Kim; Myung-Whun Sung; Dae-Seog Heo
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

9.  Recurrent oropharyngeal cancer after organ preserving treatment: pattern of failure and survival.

Authors:  M de Ridder; Z A R Gouw; J J Sonke; A Navran; B Jasperse; J Heukelom; M E T Tesselaar; W M C Klop; M W M van den Brekel; Abrahim Al-Mamgani
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-09       Impact factor: 2.503

10.  T1-T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study.

Authors:  Alain Cosmidis; Jean-Pierre Rame; Olivier Dassonville; Stéphane Temam; François Massip; Gilles Poissonnet; Marc Poupart; Patrick Marandas; Dominique De Raucourt
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-09       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.